EU regulator conditionally approves Abbott's purchase of St Jude
BRUSSELS (Reuters) - The European Commission on Wednesday said it has given its conditional approval to U.S. medical device maker Abbott Laboratories' (ABT.N: Quote) bid for peer St Jude Medical Inc STJ.N.
Reuters reported on Nov. 15 that the $25 billion deal was going to be cleared in Brussels.
The European Commission, the mergers regulator, said in a statement that its approval was conditional on "Abbott divesting two devices used in cardiovascular treatments."
(Reporting by Gabriela Baczynska)
© Thomson Reuters 2017 All rights reserved.